講師
- 籌備委員會成員
- 國際委員會
- 2024 公司展望說明會
- Session 1 (Plenary) – Global Biotech Development
- Session 2 (Plenary) – Global Biotech Development
- Session 3 (Plenary) – Through International Alignment for a Heal
- Session 4 – ADC Drug development and manufacturing trends chall
- Session 5 – Frontier of Gene and Cell Therapies
- Session 6 – mRNA and New Therapeutic Modalities
- Session 8 – Strategic Insights into CMC Program Design: Pioneeri
- Session 10 – Translational Medicine, A Journey from Novelty to C
- Session 11 – AI for Pharma
- Session 12– Advances in Genetics and Precision Medicine in Human
- Investment Summit
- 2024 Satellite Symposia
- Session 13 – Shaping the Future of Digital Health
- Satellite Symposia - LumiStar
- Satellite Symposia - JelloX
- Regional Collaboration Forum-Japan
- Regional Collaboration Forum-Belgian
- Regional Collaboration Forum-Thailand
- Regional Collaboration Forum-Malaysia
- Session 09 – BIO Asia–Taiwan 2024 Opening & Award Ceremony
- Regional Collaboration Forum-Plenary
- Session 7- Taiwan BIO Awards-Successful Stories
- Satellite Symposia-CSL
Servina Liu
Satellite Symposia – 3D Imaging with Tissue Clearing for Clinical Translation – from Neuroscience to Pathology Diagnosis
Time：16:40-17:10 (GMT+8)
Servina Liu
CSO
JelloX Biotech Inc.
.
Speech title & Synopsis
Transforming Pathology through Digital Innovation and New Frontier of 3D Imaging- The Mayo Clinic Experience
Moderator